Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

244.39
+3.091.28%
Post-market: 244.390.00000.00%19:30 EDT
Volume:1.26M
Turnover:307.88M
Market Cap:26.97B
PE:25.95
High:244.70
Open:240.33
Low:239.43
Close:241.30
52wk High:245.68
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:1.61
T/O Rate:1.15%
Dividend:3.32
Dividend Rate:1.36%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.59
PE(LYR):27.93

Loading ...

City of Hope evaluates Quest’s Haystack MRD test in multi-cancer clinical trials

Reuters
·
Apr 16

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Apr 15

Baird Adjusts Price Target on Quest Diagnostics to $224 From $219, Maintains Neutral Rating

MT Newswires Live
·
Apr 14

Earning Preview: Quest Diagnostics Q1 revenue is expected to increase by 7.47%, and institutional views are broadly constructive

Earnings Agent
·
Apr 14

Assessing Quest Diagnostics (DGX) Valuation As Long Term Returns Draw Fresh Investor Attention

Simply Wall St.
·
Apr 11

Quest Diagnostics Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Apr 08

Quest Diagnostics target cut, added to ‘Tactical Outperform’ list at Evercore

TIPRANKS
·
Apr 08

Evercore ISI Adjusts Price Target on Quest Diagnostics to $210 From $220, Maintains In Line Rating

MT Newswires Live
·
Apr 08

Quest Diagnostics announces annual shareholder meeting

Reuters
·
Apr 07

PRECIOUS-Gold slips as markets assess prospects of Iran ceasefire

Reuters
·
Mar 26

How Investors May Respond To Quest Diagnostics (DGX) Expanding Blood-Based Cancer Screening And Boardroom Expertise

Simply Wall St.
·
Mar 22

Quest Diagnostics to report first-quarter 2026 results and host earnings call

Reuters
·
Mar 19

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared To Competitors

Dow Jones
·
Mar 19

Quest Diagnostics Files Initial Beneficial Ownership Statement for Director Timothy C. Wentworth

Reuters
·
Mar 12

Argus Adjusts Price Target on Quest Diagnostics to $225 From $210, Maintains Buy Rating

MT Newswires Live
·
Mar 10

Quest Diagnostics Inc : Argus Research Raises Target Price to $225 From $210

THOMSON REUTERS
·
Mar 10

Quest Diagnostics Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
Mar 07

Quest Diagnostics EVP Catherine T. Doherty disposes of common shares

Reuters
·
Mar 07

Quest Diagnostics SVP and General Counsel Michael E. Prevoznik Disposes of Common Shares

Reuters
·
Mar 07

Quest Diagnostics SVP Clinical Solutions Karthik Kuppusamy Disposes of Common Shares

Reuters
·
Mar 07